NephroGenex Inc (NASDAQ:NRX)

6.26
Delayed Data
As of 1:55pm ET
 +0.17 / +2.79%
Today’s Change
3.96
Today|||52-Week Range
17.98
-53.11%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close6.09
Today’s open6.13
Day’s range6.12 - 6.30
Volume26,813
Average volume (3 months)31,594
Market cap$58.9M
Dividend yield--
Data as of 1:55pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)-2.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...+1.09+1.34%
CBAYCymaBay Therapeutics...0.000.00%
MCPIMed Cannabis Pharma ...+0.01+2.63%
BIOSBioScrip Inc-0.15-4.34%
Data as of 2:35pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pierre Legault
President &
Chief Scientific Officer
J. Wesley Fox Ahmann
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers